# Synthetic Analogs of the Alkaloid Cassiarin A with Enhanced Antimalarial Activity

**Authors:** Thomas Klaßmüller, Timo Reiß, Florian Lengauer, Che Julius Ngwa, Karin Bartel, Gabriele Pradel, Franz Bracher

PMC · DOI: 10.3390/ph18071018 · Pharmaceuticals · 2025-07-09

## TL;DR

Scientists created new versions of a natural compound called cassiarin A that show stronger antimalarial effects but are toxic to human cells.

## Contribution

The study introduces new cassiarin A analogs with improved antimalarial activity and explores their structure-activity relationships.

## Key findings

- Adding a benzene ring at C-2 significantly improved antiprotozoal activity against Plasmodium falciparum.
- Modifications at C-5 and the phenolic group reduced activity.
- Two analogs showed resistance indices similar to chloroquine but caused strong cytotoxicity in human cells.

## Abstract

Background: Among the alkaloids from Cassia siamea, cassiarin A has outstanding antiprotozoal activity, but structure–activity relationships for this chemotype were only poorly understood until now. Methods: We worked out efficient approaches to hitherto underexplored analogs (12 examples) on three synthesis routes which mainly comprised variations in the methyl groups at C-2 and C-5. The new compounds were tested for antiprotozoal and cytotoxic activities. Results: Introduction of a (substituted) benzene ring at C-2 led to a significant enhancement of activity against Plasmodium falciparum, while modifications of the methyl group at C-5 and the phenolic group had detrimental effects. Two of the 2-phenyl analogs further showed a resistance index comparable to the one of the reference drug chloroquine. Although the novel derivatives did not show hemolytic effects, investigation on human endothelial (HUVEC) cells at relevant concentrations indicated strong cytotoxic effects on human cells. Conclusions: Systematic structure modifications of cassiarin A led to a significant enhancement of antiplasmodial activity, but the observed strong cytotoxicity to human cells renders this library of cassiarin A derivatives inadequate for drug development.

## Linked entities

- **Chemicals:** cassiarin A (PubChem CID 17756117), chloroquine (PubChem CID 2719)
- **Diseases:** malaria (MONDO:0005136)
- **Species:** Plasmodium falciparum (taxon 5833), Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** cytotoxic (MESH:D064420), hemolytic (MESH:D006461)
- **Chemicals:** Cassiarin A (MESH:C524027), chloroquine (MESH:D002738), alkaloids (MESH:D000470)
- **Species:** Senna siamea (species) [taxon 346999], Homo sapiens (human, species) [taxon 9606], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833]
- **Cell lines:** HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12299140/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12299140/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12299140/full.md

---
Source: https://tomesphere.com/paper/PMC12299140